a holding company which engages in the discovery and development of novel cell therapies for oncology and other indications
Industry Biotechnology
A.I.dvisor tells us that LEGN and BGNE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEGN and BGNE's prices will move in lockstep.
Ticker / NAME | Correlation To LEGN | 1D Price Change % | ||
---|---|---|---|---|
LEGN | 100% | +1.37% | ||
BGNE - LEGN | 33% Poorly correlated | -1.11% | ||
NUVL - LEGN | 28% Poorly correlated | -0.18% | ||
IMTX - LEGN | 27% Poorly correlated | -0.47% | ||
BHVN - LEGN | 27% Poorly correlated | -0.77% | ||
RYTM - LEGN | 27% Poorly correlated | -0.50% | ||
More |
Ticker / NAME | Correlation To LEGN | 1D Price Change % |
---|---|---|
LEGN | 100% | +1.37% |
novel cell therapies theme (2 stocks) | 100% Closely correlated | -0.24% |
biotech theme (2 stocks) | 98% Closely correlated | -0.51% |
oncology theme (18 stocks) | 29% Poorly correlated | -2.90% |
china theme (161 stocks) | 25% Poorly correlated | -1.23% |